Educational Activities

DNA Educational Activities

Welcome to our online issues of Dermatology Nurse Practice

This is a series of print and online educational resources that is developed by the Dermatology Nurses’ Association thanks to unrestricted educational grants from Incyte and Pfizer. We hope that you find the information in this and subsequent publications of informational and educational value as you progress in your career as a dermatology nurse. If there are topics you’d like to learn about in the future or if you have any feedback on this education, please don’t hesitate to drop us a note at dna@dnanurse.org. We’d love to hear from you!

This Education Offering is provided FREE of charge!

The Dermatology Nurses’ Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

To Receive Credit:

Watch the broadcast in its entirety.
Complete/submit the post test and evaluation.
Receive a passing score of 70% or more to receive credit.
Print out your certificate, as well as save it to your computer.

DNP Challenging Cases in Dermatology – AD – Broadcast #3

PROGRAM OVERVIEW
Program Purpose: Single-nucleotide polymorphism analyses and genome-wide association studies have implicated more than 60 genes that play a role in the development of AD, many of which relate either to innate and adaptive immunity or skin barrier function. Such complexity helps explain why different patients respond differently to the same AD treatment and points to a need for a diverse pharmacopeia with varied mechanisms of action. There is a significant need for safe and effective systemic AD therapies.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:
Describe the challenges of treating moderate-to-severe atopic dermatitis in young children.
Develop strategies that may help families stick to complex treatment regimens over extended periods of time.

To Receive Credit:

Watch the broadcast in its entirety.
Complete/submit the post test and evaluation.
Receive a passing score of 70% or more to receive credit.
Print out your certificate, as well as save it to your computer.

DNP Challenging Cases in Dermatology – AD – Broadcast #2

PROGRAM OVERVIEW
Program Purpose: Develop strategies to help bridge language, cultural, and socioeconomic barriers to effective AD care.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:
Describe the challenges of treating moderate-to-severe atopic dermatitis in children.
Develop strategies that address parental involvement with children who have moderate-to-severe atopic dermatitis.

To Receive Credit:

Watch the broadcast in its entirety.
Complete/submit the post test and evaluation.
Receive a passing score of 70% or more to receive credit.
Print out your certificate, as well as save it to your computer.

DNP Challenging Cases in Dermatology – AD – Broadcast #1

PROGRAM OVERVIEW
Program Purpose: Education is warranted to bring these providers up to speed so that they can better educate their patients regarding the “how and why” of their disease development.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:
Describe the challenges of treating moderate-to-severe atopic dermatitis in patients with skin of color.
Discuss comorbid conditions commonly found among patients diagnosed with atopic dermatitis.

The Impact of Atopic Dermatitis on Quality of Life: A Patient Perspective

VOLUME 1 | ISSUE 4

Release Date: October 27, 2022

Expiration Date: October 27, 2023

INSIDE THIS ISSUE:

What are some of the most common (and challenging) quality of life issues among patients with atopic dermatitis (AD)?

How do parents of young children with AD manage to maintain optimism in the face of the many issues faced by their families?

How do patients with AD deal with emergency situations that arise in their lives?

What do patients with AD want and expect of their healthcare providers?

DNP Trends in the Use of Systemic Therapies: Where We Are and Where We’re Going

VOLUME 1 | ISSUE 3

Release Date: July 15, 2022

Expiration Date: July 15, 2023

INSIDE THIS ISSUE:

Why are systemic therapies so important to help control disease activity in patients with moderate to severe atopic dermatitis (AD)?

How has the introduction of dupilumab changed the short- and long-term prognosis of patients with moderate to severe AD?

What impact might the recent introduction of additional FDA approved systemic therapies have on the care of patients with moderate to severe AD?

What are some of the class specific safety concerns with systemic agents either recently approved or under late-stage investigation for the treatment of AD?

DNP Managing Atopic Dermatitis in Patients with Skin of Color

VOLUME 1 | ISSUE 2

Release Date: June 1, 2022

Expiration Date: June 1, 2023

INSIDE THIS ISSUE:

What exactly is a “healthcare disparity?”

How is the clinical appearance of atopic dermatitis (AD) lesions among patients with skin of color unique?

What is known about the prevalence of hypopigmentation and skin atrophy among AD patients with skin of color?

Why is it a bad idea to let family members serve as medical translators for patients who are non-native English speakers?

DNP Pathophysiology of Atopic Dermatitis: A Nursing Primer

VOLUME 1 | ISSUE 1

Release Date: December 15, 2021

Expiration Date: December 15, 2022

INSIDE THIS ISSUE:

What is driving the increased prevalence of atopic dermatitis (AD) both in the United States and around the globe?

What are the differences between the “inside-out” and “outside-in” theories that have been proposed to help explain why AD develops in some individuals but not others?

How common is the “atopic march” among infants who are diagnosed with AD?

What are some of the more common pathways targeted by therapies commonly used to treat AD?